General Biologicals Corporation (GBC)
Biotechnology Research • 
No.6, Innovation First Road, Taiwan, Province of China • 21-50 Employees
Company overview
| Headquarters | No.6, Innovation First Road, Hsinchu Science Park, Hsin Chu, 30076, TW |
| Phone number | +88635779221 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Immunoassay, Molecular Diagnostics, Elisa, Clia, Point-Of-Care Tests, Cellbio Technology - Ctc (Circulating Tumor Cell), Hbv/Hcv/Hiv Elisa, Hbv/Hcv/Hiv Real-Time Pcr |
| Founded | 1984 |
| Employees | 21-50 |
| Socials |
Key Contact at General Biologicals Corporation (GBC)
Wally Fan
Director, International Sales
General Biologicals Corporation (GBC) Email Formats
General Biologicals Corporation (GBC) uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@gbc.com.tw), used 66.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@gbc.com.tw | 66.7% |
{first name}.{last name} | john.doe@gbc.com.tw | 33.3% |
About General Biologicals Corporation (GBC)
General Biologicals Corporation (GBC) — Advancing Diagnostics, Empowering Better Health Founded in 1984, GBC is a pioneer in Taiwan’s in-vitro diagnostics (IVD) industry, originating from the National Hepatitis Prevention Program. For over 40 years, we have dedicated ourselves to developing accessible, accurate, and innovative diagnostic solutions that improve healthcare outcomes worldwide. As a GMP-certified and ISO 13485-compliant manufacturer, GBC specializes in the research, development, production, and global distribution of IVD products. Today, our solutions are trusted in over 40 countries, serving hospitals, clinical laboratories, blood banks, and healthcare professionals with reliable diagnostic tools. Core Expertise: • Infectious & Respiratory Diseases • Blood-Borne Viruses • Fertility & Sexual Health • Oncology & Tumor Markers • Human Genetics • Emerging Infectious Diseases GBC has built a fully integrated value chain — from R&D and manufacturing to clinical applications and laboratory services — leveraging cutting-edge protein and nucleic acid platforms to drive innovation in diagnostics. Looking forward, we are expanding beyond traditional IVD into high-value, integrated healthcare solutions through our subsidiaries: • CurieMed & Danner Lab — Digital medical diagnostics and clinical laboratory services • GBP — Antimicrobial peptide (AMP) drug development and consumer health applications With a strong global presence, innovative technologies, and a mission to make quality diagnostics affordable for all, GBC continues to transform healthcare and empower better lives.
General Biologicals Corporation (GBC) revenue & valuation
| Annual revenue | $1,967,765 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $6,300,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
General Biologicals Corporation (GBC) has 9 employees across 5 departments.
Departments
Number of employees
Funding Data
General Biologicals Corporation (GBC) has never raised funding before.
General Biologicals Corporation (GBC) Tech Stack
Discover the technologies and tools that power General Biologicals Corporation (GBC)'s digital infrastructure, from frameworks to analytics platforms.
CDN
CDN
PaaS
JavaScript libraries
Tag managers
Reverse proxies
Programming languages
JavaScript frameworks
Miscellaneous
JavaScript libraries
United States![Perform[cb]](https://static.prospeo.io/directory-image/company_logo/8c2dc425-b576-4d7e-a0bb-574e45fb9e20.jpg){kind=logo}
France
United Kingdom
Ireland
Saudi Arabia
Iceland
PortugalFrequently asked questions
4.8
40,000 users
